This pharmacoepidemiology study uses Medicare Part D data to describe changes in use of prescription drugs associated with an increase in fracture risk before and after fragility fractures.
The Viewpoint discusses the effects of “patent trolls” on generic drug prices and availability.
In a nationally representative sample of older adults, this study characterizes changes in the prevalence of medication use and quantifies the frequency and types of potential major drug-drug interactions.
This Viewpoint discusses the implications of recent circuit court decisions regarding commercial speech and off-label marketing of prescription drugs.
This pharmacoepidemiology study assessed medication adherence before and after implementation of narrow insurance networks within commercial drug plans.
This study describes the development and validation of a screening instrument for drug use disorders and negative consequences of drug use for use in primary care clinics.
A newly proposed US Food and Drug Administration guidance could undermine the agency's drug safety laws and regulations by allowing pharmaceutical companies to claim their drugs are less risky than stated in the approved label.
Austad and colleagues set out to determine whether there is an association between medical trainees’ interactions with pharmaceutical promotion and their preferences in medication use. Ross elucidates in the Editor’s Note.